Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: A prospective cohort study
In this prospective cohort of IBD outpatients, 10 % and 20 % of patients had sarcopenia and myopenia, respectively. Screening for sarcopenia therefore seems essential in this population, including in stable outpatients in remission who do not meet malnutrition criteria and in overweight patients, as according to the literature, sarcopenia is associated with poorer clinical outcomes and increased postoperative complications. Interventional studies are needed to assess the impact of multidisciplinary treatment of sarcopenia on quality of life and disease progression.
Authors
- Solène Dermine (ORCID: https://orcid.org/0000-0003-4848-115X)
- Olivier Corcos (ORCID: https://orcid.org/0000-0002-9034-7053)
- Clément Bresteau (ORCID: https://orcid.org/0000-0003-3506-1519)
- J. Bettolo
- Francisca Joly (ORCID: https://orcid.org/0000-0002-9341-7133)
- Lore Billiauws
- C. Hutinet
- Thomas Bazin (ORCID: https://orcid.org/0000-0002-3262-3902)
- Alexandre Nuzzo (ORCID: https://orcid.org/0000-0002-8952-7620)
- Ashiq Mohamed Gouse
- Justine Bourdillel
- Mona El Khatib
- Fatimé Adam Hassan
Institutions
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
Publication Details
- Journal
- Clinics and Research in Hepatology and Gastroenterology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1016/j.clinre.2025.102555
- Citations
- 2
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 2.33